trial
as of 2026-07-01Valacyclovir Augmentation for Cognitive and Functional Remediation in Schizophrenia
NCTId NCT01794897
at a glance
Phase 4 · Completed
Enrollment 134 (actual)
Sponsored by University of Pittsburgh Medical Center
Primary completion 2016-09
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
134 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Triple
Start
2013-02
Primary completion
2016-09
Eligibility
ALL · 18 Years · 50 Years
Interventions & indications
Sponsors
University of Pittsburgh Medical CenterLead Sponsor
Dr. Ram Manohar Lohia HospitalCollaborator
Stanley Medical Research InstituteCollaborator
Investigators
2
Vishwajit Laxmikant Nimgaonkar, MD PhDPrincipal Investigator
Smita Deshpande, MDPrincipal Investigator
Sites
1 total
Delhi, India
Facts & assertions
4 sourced
Enrollment
134
Phase
PHASE4
Primary Completion Date
2016-09
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
collaborator
indication
investigator